This announcement is a separate document:
共同药业：2023年度独立董事述职报告（夏成才）
Hubei Goto Biopharm: 2023 Independent Director Debriefing Report (Xia Chengcai)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated